Rabourn Amy Zaremba - 22 Jan 2026 Form 4 Insider Report for Opus Genetics, Inc. (IRD)

Role
Head of Fin. Quality Assurance
Signature
/s/ Amy Rabourn
Issuer symbol
IRD
Transactions as of
22 Jan 2026
Net transactions value
$0
Form type
4
Filing time
26 Jan 2026, 19:49:14 UTC
Previous filing
21 Jan 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Zaremba Rabourn Amy Head of Fin. Quality Assurance C/O OPUS GENETICS, INC., 8 DAVIS DRIVE, SUITE 220, DURHAM /s/ Amy Rabourn 26 Jan 2026 0001832343

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IRD Common Stock Award $0 +86,500 +81% $0.000000 193,128 22 Jan 2026 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a grant of restricted stock units which vest in substantially equal quarterly installments on the anniversary of the grant date over the next sixteen (16) quarters, subject to the Reporting Person's continuing service.